6/21/2024Chinas NMPA Meets US Counterpart in First High-level Meeting at FDA HQ...

6/21/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Stu...

6/21/2024CDE Issues the Technical Guidelines for Clinical Trial of Viral Infect...

6/19/2024China Made Advances in Pharma Innovation and Quality: NMPA Official

6/18/2024CDE Solicits Comments on the Technical Requirements for the Pharmaceut...

6/17/2024NMPA Announces Package Insert Revision of Cyclophosphamide Adenosine, ...

6/17/2024CDE Solicits Comments on the Guidelines for Clinical Trial Design of N...

6/17/2024CDE Issues the List of Reference Formulations for GQCE Studies (81st B...

6/14/2024CDE Issues the Technical Guidelines for the Assessment of Adverse Even...

6/14/2024CDE Issues the Dossier Requirements for Marketing Registration Applica...

6/14/2024CDE Issues Two Pharmaceutical Change Research Guidelines

6/13/2024CDE Issues the Technical Guidelines for Post-Marketing Pharmaceutical ...

6/12/2024CDE Issues the Technical Guidelines for Pharmaceutical Research on Com...

6/12/2024CDE Issues the Technical Guidelines for Pharmaceutical Research of Gen...

6/12/2024NMPA Issues Revised Blood Product Appendix of Chinese Drug GMP 2010

6/12/2024NMPA Issues the Technical Guidelines for Electronic Recording of Blood...

6/11/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (83...

6/7/2024CDE Solicits Comments on the Guidelines for Pediatric Clinical Trial D...

6/6/2024FDA Blasts Jiangsu Hengrui for Obstructing Inspection and Manufacturin...

6/3/2024CDE Solicits Comments on the Guidelines for Evaluating the Pharmacokin...

5/31/2024CDE Solicits Comments on the Technical Guidelines for the Analysis and...

5/31/2024China Has Approved 21 Children's Medicines in 2024

5/30/2024NHC Publicizes the List of Pediatric Drugs Encouraged for R&D and Regi...

5/30/2024CDE Issues the Technical Guidelines for Application of Decentralized C...

5/28/2024NMAP Issues the Implementation Suggestions and Chinese Translation of ...

5/28/2024NMPA Issues Announcement on Pediatric Use Info Addition to the Package...

5/28/2024NMPA Holds Meeting to Review Vaccine Regulatory QMS

5/24/2024CDE Solicits Comments on CARE Plan for Rare Disease Drugs

5/23/2024CDE Issues the List of Reference Formulations for GQCE Studies (80th B...

5/23/2024NMPA Issues Announcement for Applicability of ICH Guidelines Q5A(R2)

Page:7/8 Total number of articles:223: [First][<<] [4] [5] [6] [7] [8] [>>] [End]